Form 4: Agenus Director Wright Boosts Deferred Stock Holdings

Agenus Inc. Director Timothy Wright acquired 2,040.576 deferred stock units as part of a compensation plan, increasing his total beneficial ownership to 23,913.006 units.

Summary

• Timothy Wright, a Director of Agenus Inc., acquired 2,040.576 Deferred Stock Units (DSUs).
• The acquisition occurred on January 2, 2026.
• DSUs convert to shares of Common Stock on a 1-for-1 basis.
• The DSUs were acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended.
• The price per DSU was $3.982, calculated as the average closing price of the company's common stock for the calendar quarter immediately preceding the acquisition date.
• Following this transaction, Mr. Wright beneficially owns 23,913.006 Deferred Stock Units.
• These units are typically distributed as common stock once the director ceases to serve as a director of the company.

Sentiment

Score: 6

Explanation: Slightly positive. While a routine compensation event, it increases a director's beneficial ownership, aligning their interests with shareholders. It's not a direct cash investment, so the positive sentiment is moderate.

Positives

• Increased beneficial ownership by a director, indicating continued alignment with shareholder interests.
• The transaction is part of a structured compensation plan, reflecting standard corporate governance practices.

Negatives

• The acquisition is not a direct open-market purchase, but rather compensation, which may not signal new confidence in the same way a cash purchase would.

Future Outlook

This filing does not contain any forward-looking statements or guidance beyond the nature of the Deferred Stock Units converting to common stock upon the director ceasing service.

Industry Context

Director compensation often includes equity-based awards like deferred stock units to align the interests of directors with those of shareholders. This is a common practice in the biotechnology and pharmaceutical industry, where long-term value creation is paramount.

Comparison to Industry Standards

• The use of Deferred Stock Units as part of director compensation is a standard practice across many publicly traded companies, including those in the biotechnology sector.
• While specific plan details vary, the general mechanism of granting equity that vests or is distributed upon cessation of service is common.
• No specific comparable companies or projects are mentioned in this filing to allow for a detailed comparative assessment of the compensation structure itself.

Corporate Governance

Related Party Transactions

• The acquisition of Deferred Stock Units by a director from the company under a compensation plan constitutes a related party transaction.

Stakeholder Impact

• Shareholders: Increased alignment of a director's interests with shareholders due to higher equity ownership.

Next Steps

• The Deferred Stock Units will convert to shares of Common Stock on a 1-for-1 basis, typically once Timothy Wright ceases to serve as a director of Agenus Inc.

Key Dates

Keywords

Agenus Inc., AGEN, Timothy Wright, Director compensation, Deferred Stock Units, Insider transaction, Form 4, Beneficial ownership, Equity compensation